Citation
Ye, Chun-Lin, et al. "In Vivo Antitumor Activity By 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a Solid Human Carcinoma Xenograft Model." Cancer Chemotherapy and Pharmacology, vol. 56, no. 1, 2005, pp. 70-4.
Ye CL, Liu JW, Wei DZ, et al. In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a solid human carcinoma xenograft model. Cancer Chemother Pharmacol. 2005;56(1):70-4.
Ye, C. L., Liu, J. W., Wei, D. Z., Lu, Y. H., & Qian, F. (2005). In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a solid human carcinoma xenograft model. Cancer Chemotherapy and Pharmacology, 56(1), 70-4.
Ye CL, et al. In Vivo Antitumor Activity By 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a Solid Human Carcinoma Xenograft Model. Cancer Chemother Pharmacol. 2005;56(1):70-4. PubMed PMID: 15806415.
TY - JOUR
T1 - In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a solid human carcinoma xenograft model.
AU - Ye,Chun-Lin,
AU - Liu,Jian-Wen,
AU - Wei,Dong-Zhi,
AU - Lu,Yan-Hua,
AU - Qian,Feng,
Y1 - 2005/04/02/
PY - 2004/05/11/received
PY - 2004/08/13/accepted
PY - 2005/4/5/pubmed
PY - 2005/7/6/medline
PY - 2005/4/5/entrez
SP - 70
EP - 4
JF - Cancer chemotherapy and pharmacology
JO - Cancer Chemother Pharmacol
VL - 56
IS - 1
N2 - Previously we have shown that 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone (DMC), which is isolated from the buds of Cleistocalyx operculatus, significantly inhibits the growth of human liver cancer SMMC-7721 cells and is able to induce apoptosis of SMMC-7721 cells in vitro. Here we report the antitumor effects of DMC in vivo, using a solid human tumor xenograft mouse model using human liver cancer SMMC-7721 cells. The average tumor weights in the control group and in mice injected with 150 mg/kg DMC were 1.42+/-0.11 g and 0.59+/-0.12 g, respectively. Flow cytometric analysis of the tumor cell population demonstrated an aneuploid peak (representing 33.60+/-0.80% of the total in mice injected with 150 mg/kg DMC). To our knowledge, this is the first time that chalcone compounds have been applied to a human tumor xenograft model.
SN - 0344-5704
UR - https://www.unboundmedicine.com/medline/citation/15806415/In_vivo_antitumor_activity_by_2'4'_dihydroxy_6'_methoxy_3'5'_dimethylchalcone_in_a_solid_human_carcinoma_xenograft_model_
DB - PRIME
DP - Unbound Medicine
ER -